{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:37:23Z","timestamp":1782772643666,"version":"3.54.5"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32DA024628-15"],"award-info":[{"award-number":["T32DA024628-15"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA048042"],"award-info":[{"award-number":["R01DA048042"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA048042"],"award-info":[{"award-number":["R01DA048042"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>The extent to which the documented association between prenatal prescribed opioid analgesic (POA) exposure and neurodevelopmental disorders in children is causal or due to confounding is unknown. The objective of this study was to evaluate associations between dose and duration of POA exposure during pregnancy and autism spectrum disorder (ASD) or attention-deficit\/hyperactivity disorder (ADHD) in children while minimizing bias due to confounding and other sources.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods and findings<\/jats:title>\n<jats:p>This retrospective study analyzed a population-based cohort of births using national register data from Sweden. The ASD analysis cohort consisted of 1,267,978 children born in Sweden from July 1st, 2007 to December 31st, 2018, with follow-up through 2021. A shorter eligibility period was used to study ADHD given its later age of typical diagnosis, consisting of 918,771 children born through December 31st, 2015. Text-mining algorithms were used to derive cumulative dose and duration of POA exposure during pregnancy from filled POA prescriptions, as well as to identify prescriptions that were to be taken on an \u201cas needed\u201d basis. Outcomes were identified through inpatient or outpatient clinical diagnosis of ASD and ADHD or dispensed ADHD medications. Cox proportional hazards regression models were adjusted for measured covariates from multiple domains. Several designs were used to help address unmeasured confounding: comparisons with children whose birthing parent had a diagnosed painful condition but did not receive POAs, children whose birthing parent received POAs in the year before but not during pregnancy, and siblings who were not exposed to POAs. Of the 1,267,978 children, 48.6% were female and 4.4% were exposed to POAs during pregnancy. At age 10, cumulative incidence of ASD was 2.0% among children unexposed to POAs, 2.9% among children exposed to a low dose across pregnancy, and 3.6% among children exposed to a high dose. In unadjusted models (e.g., hazard ratio [HR]<jats:sub>high<\/jats:sub>, 1.74, 95% confidence interval [CI], 1.63, 1.87) and when accounting for measured covariates, cumulative maximum dose was associated with increased risk of ASD (e.g., HR<jats:sub>high<\/jats:sub>, 1.34, 95% CI, 1.24, 1.44). However, the associations were largely or fully attenuated when using alternative designs (particularly when comparing to children whose birthing parent received POAs before but not during pregnancy: HR<jats:sub>high<\/jats:sub>, 1.10, 95% CI, 1.00, 1.21). No associations were observed in the sibling comparison (HR<jats:sub>high<\/jats:sub>, 0.99, 95% CI, 0.81, 1.21). This overall pattern of associations was also observed when considering duration of exposure, and in numerous sensitivity analyses, as well as for analyses of ADHD. A main limitation of this study was that the distribution of dose and duration of POAs prescribed to birthing parents in Sweden limited our ability to explore the effects of extremely high dose and duration on risk for neurodevelopmental disorders.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>While increased risks with high amounts of POA exposure cannot be ruled out, the results suggest that confounding may largely explain the increased risks of ASD and ADHD associated with prenatal POA exposure at the levels observed in this cohort.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pmed.1004721","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T17:21:38Z","timestamp":1758043298000},"page":"e1004721","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prescribed opioid analgesic use in pregnancy and risk of neurodevelopmental disorders in children: A retrospective study in Sweden"],"prefix":"10.1371","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6929-544X","authenticated-orcid":true,"given":"Emma N.","family":"Cleary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4374-9949","authenticated-orcid":true,"given":"Ayesha C.","family":"Sujan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin E.","family":"Rickert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8655-6505","authenticated-orcid":true,"given":"Franziska","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyra","family":"Lagerberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Lichtenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6770-8762","authenticated-orcid":true,"given":"Patrick D.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6638-1895","authenticated-orcid":true,"given":"Anna Sara","family":"\u00d6berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5248-7434","authenticated-orcid":true,"given":"Brian M.","family":"D\u2019Onofrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"issue":"2","key":"pmed.1004721.ref001","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3233\/BMR-140527","article-title":"Women\u2019s experiences of low back pain during pregnancy","volume":"28","author":"MJ Mota","year":"2015","journal-title":"J Back Musculoskelet Rehabil"},{"issue":"1","key":"pmed.1004721.ref002","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1186\/s12884-023-06151-x","article-title":"The global prevalence of low back pain in pregnancy: a comprehensive systematic review and meta-analysis","volume":"23","author":"N Salari","year":"2023","journal-title":"BMC Pregnancy Childbirth"},{"key":"pmed.1004721.ref003","first-page":"6985164","article-title":"Chronic pain prevalence and exposures during pregnancy","volume":"2019","author":"SL Ray-Griffith","year":"2019","journal-title":"Pain Res Manag"},{"issue":"2","key":"pmed.1004721.ref004","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2023.12.020","article-title":"Prescription medication use during pregnancy in the United States from 2011 to 2020: trends and safety evidence","volume":"231","author":"O Mansour","year":"2024","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"pmed.1004721.ref005","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/pds.4577","article-title":"Trends in prescription drug use during pregnancy and postpartum in Norway, 2005 to 2015","volume":"27","author":"A Engeland","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"pmed.1004721.ref006","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/jamapediatrics.2022.4892","article-title":"Patterns in prescription opioids, benzodiazepines, and stimulants filled by pregnant medicaid beneficiaries","volume":"177","author":"A Meinhofer","year":"2023","journal-title":"JAMA Pediatr"},{"issue":"1","key":"pmed.1004721.ref007","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/jnr.24642","article-title":"Clinical and basic research investigations into the long-term effects of prenatal opioid exposure on brain development","volume":"100","author":"T Boggess","year":"2022","journal-title":"J Neurosci Res"},{"issue":"1","key":"pmed.1004721.ref008","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/npp.2014.147","article-title":"Developmental consequences of fetal exposure to drugs: what we know and what we still must learn","volume":"40","author":"EJ Ross","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"pmed.1004721.ref009","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s40264-021-01080-0","article-title":"Association between prenatal opioid exposure and neurodevelopmental outcomes in early childhood: a retrospective cohort study","volume":"44","author":"X Wen","year":"2021","journal-title":"Drug Saf"},{"key":"pmed.1004721.ref010","article-title":"Prenatal opioid exposure and subsequent risk of neuropsychiatric disorders in children: nationwide birth cohort study in South Korea","volume":"385","author":"J Kang","year":"2024","journal-title":"BMJ"},{"issue":"1","key":"pmed.1004721.ref011","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s10803-018-3721-8","article-title":"Brief report: maternal opioid prescription from preconception through pregnancy and the odds of autism spectrum disorder and autism features in children","volume":"49","author":"E Rubenstein","year":"2019","journal-title":"J Autism Dev Disord"},{"issue":"9","key":"pmed.1004721.ref012","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.24324","article-title":"Association of timing and duration of prenatal analgesic opioid exposure with attention-deficit\/hyperactivity disorder in children","volume":"4","author":"JN Tr\u00f8nnes","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"6","key":"pmed.1004721.ref013","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/pds.4170","article-title":"Language competence and communication skills in 3-year-old children after prenatal exposure to analgesic opioids","volume":"26","author":"E Skovlund","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"pmed.1004721.ref014","doi-asserted-by":"crossref","DOI":"10.5324\/nje.v24i1-2.1824","article-title":"Self-reported data on medicine use in the Norwegian Mother and Child cohort study compared to data from the Norwegian Prescription Database","volume":"24","author":"S Skurtveit","year":"2014","journal-title":"Norsk epidemiologi"},{"key":"pmed.1004721.ref015","doi-asserted-by":"crossref","first-page":"148616","DOI":"10.1155\/2012\/148616","article-title":"The problem of confounding in studies of the effect of maternal drug use on pregnancy outcome","volume":"2012","author":"B K\u00e4ll\u00e9n","year":"2012","journal-title":"Obstet Gynecol Int"},{"key":"pmed.1004721.ref016","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev-clinpsy-032816-045030","article-title":"Accounting for confounding in observational studies","volume":"16","author":"BM D\u2019Onofrio","year":"2020","journal-title":"Annu Rev Clin Psychol"},{"issue":"7","key":"pmed.1004721.ref017","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/pds.4789","article-title":"Use of real-world evidence from healthcare utilization data to evaluate drug safety during pregnancy","volume":"28","author":"KF Huybrechts","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"pmed.1004721.ref018","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-0035-1556740","article-title":"Prescription opioids in pregnancy and birth outcomes: a review of the literature","volume":"4","author":"MM Yazdy","year":"2015","journal-title":"J Pediatr Genet"},{"issue":"4","key":"pmed.1004721.ref019","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/jcpp.13004","article-title":"Annual Research Review: maternal antidepressant use during pregnancy and offspring neurodevelopmental problems\u2014a critical review and recommendations for future research","volume":"60","author":"AC Sujan","year":"2019","journal-title":"J Child Psychol Psychiatry"},{"issue":"1","key":"pmed.1004721.ref020","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1186\/s12888-021-03547-x","article-title":"Time of onset and\/or diagnosis of ADHD in European children: a systematic review","volume":"21","author":"I Rocco","year":"2021","journal-title":"BMC Psychiatry"},{"issue":"4","key":"pmed.1004721.ref021","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1177\/1362361320971107","article-title":"Age at autism spectrum disorder diagnosis: a systematic review and meta-analysis from 2012 to 2019","volume":"25","author":"M van \u2019t Hof","year":"2021","journal-title":"Autism"},{"key":"pmed.1004721.ref022","volume-title":"Multi-generation register 2009\u2014a description of contents and quality","author":"Statistics Sweden.","year":"2010"},{"issue":"7","key":"pmed.1004721.ref023","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/pds.1294","article-title":"The new Swedish Prescribed Drug Register\u2014opportunities for pharmacoepidemiological research and experience from the first six months","volume":"16","author":"B Wettermark","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"pmed.1004721.ref024","volume-title":"4 years with the Prescribed Drug Register [in Swedish]","year":"2010"},{"key":"pmed.1004721.ref025","volume-title":"The Swedish Medical Birth Register\u2014a summary of content and quality","author":"National Board of Health and Welfare.","year":"2003"},{"key":"pmed.1004721.ref026","volume-title":"Quality and content in the patient register\u2014inpatient care discharges 1964\u20132007 and outpatient (specialized care) visits 1997\u20132007","author":"National Board of Health and Welfare.","year":"2007"},{"issue":"2","key":"pmed.1004721.ref027","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10654-016-0117-y","article-title":"Registers of the Swedish total population and their use in medical research","volume":"31","author":"JF Ludvigsson","year":"2016","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"pmed.1004721.ref028","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/ebmental-2020-300231","article-title":"Prediction of treatment dosage and duration from free-text prescriptions: an application to ADHD medications in the Swedish prescribed drug register","volume":"24","author":"L Zhang","year":"2021","journal-title":"Evid Based Ment Health"},{"issue":"6","key":"pmed.1004721.ref029","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/pds.3945","article-title":"A synthesis of oral morphine equivalents (OME) for opioid utilisation studies","volume":"25","author":"S Nielsen","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"pmed.1004721.ref030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1192\/bjp.bp.112.120808","article-title":"Risk of bipolar disorder and schizophrenia in relatives of people with attention-deficit hyperactivity disorder","volume":"203","author":"H Larsson","year":"2013","journal-title":"Br J Psychiatry"},{"key":"pmed.1004721.ref031","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h1961","article-title":"Autism phenotype versus registered diagnosis in Swedish children: prevalence trends over 10 years in general population samples","volume":"350","author":"S Lundstr\u00f6m","year":"2015","journal-title":"BMJ"},{"issue":"7","key":"pmed.1004721.ref032","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/aur.1585","article-title":"Stability of diagnostic assessment for autism spectrum disorder between 18 and 36 months in a high-risk cohort","volume":"9","author":"L Zwaigenbaum","year":"2016","journal-title":"Autism Res"},{"issue":"11","key":"pmed.1004721.ref033","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1176\/appi.ajp.161.11.2014","article-title":"Three-year predictive validity of DSM-IV attention deficit hyperactivity disorder in children diagnosed at 4-6 years of age","volume":"161","author":"BB Lahey","year":"2004","journal-title":"Am J Psychiatry"},{"issue":"12","key":"pmed.1004721.ref034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002980","article-title":"Maternal prescribed opioid analgesic use during pregnancy and associations with adverse birth outcomes: a population-based study","volume":"16","author":"AC Sujan","year":"2019","journal-title":"PLoS Med"},{"issue":"25","key":"pmed.1004721.ref035","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1080\/14767058.2021.1875436","article-title":"A nation-wide Swedish study of opioid analgesic prescribing patterns during pregnancy and associated preexisting mental health conditions","volume":"35","author":"AC Sujan","year":"2022","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"9","key":"pmed.1004721.ref036","first-page":"940","article-title":"Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan","volume":"307","author":"KH Seal","year":"2012","journal-title":"JAMA"},{"issue":"15","key":"pmed.1004721.ref037","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/sim.4780141510","article-title":"Graphical methods for assessing violations of the proportional hazards assumption in Cox regression","volume":"14","author":"KR Hess","year":"1995","journal-title":"Stat Med"},{"issue":"6","key":"pmed.1004721.ref038","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1176\/appi.ajp.2018.17040393","article-title":"Continuation of atypical antipsychotic medication during early pregnancy and the risk of gestational diabetes","volume":"175","author":"Y Park","year":"2018","journal-title":"Am J Psychiatry"},{"issue":"2","key":"pmed.1004721.ref039","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1742-7843.2007.00191.x","article-title":"Assessing intrauterine influences on offspring health outcomes: can epidemiological studies yield robust findings?","volume":"102","author":"GD Smith","year":"2008","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"3","key":"pmed.1004721.ref040","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10519-015-9769-8","article-title":"Translational epidemiologic approaches to understanding the consequences of early-life exposures","volume":"46","author":"BM D\u2019Onofrio","year":"2016","journal-title":"Behav Genet"},{"issue":"9","key":"pmed.1004721.ref041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003207","article-title":"Gestational age and the risk of autism spectrum disorder in Sweden, Finland, and Norway: a cohort study","volume":"17","author":"M Persson","year":"2020","journal-title":"PLoS Med"},{"issue":"14","key":"pmed.1004721.ref042","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1001\/jama.2024.3172","article-title":"Acetaminophen use during pregnancy and children\u2019s risk of autism, ADHD, and intellectual disability","volume":"331","author":"VH Ahlqvist","year":"2024","journal-title":"JAMA"},{"issue":"8","key":"pmed.1004721.ref043","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/papr.12814","article-title":"Medication use and pain management in pregnancy: a critical review","volume":"19","author":"E Black","year":"2019","journal-title":"Pain Pract"},{"issue":"1","key":"pmed.1004721.ref044","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1533-2500.2009.00327.x","article-title":"Pelvic girdle pain and low back pain in pregnancy: a review","volume":"10","author":"E Vermani","year":"2010","journal-title":"Pain Pract"},{"issue":"5","key":"pmed.1004721.ref045","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/1552-6909.12487","article-title":"Safe management of chronic pain in pregnancy in an era of opioid misuse and abuse","volume":"43","author":"UA Pritham","year":"2014","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"issue":"8","key":"pmed.1004721.ref046","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/pds.5614","article-title":"Bias amplification of unobserved confounding in pharmacoepidemiological studies using indication-based sampling","volume":"32","author":"VH Ahlqvist","year":"2023","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"pmed.1004721.ref047","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/EDE.0000000000000541","article-title":"Carryover effects in sibling comparison designs","volume":"27","author":"A Sj\u00f6lander","year":"2016","journal-title":"Epidemiology"},{"issue":"25","key":"pmed.1004721.ref048","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1056\/NEJMoa1312828","article-title":"Antidepressant use in pregnancy and the risk of cardiac defects","volume":"370","author":"KF Huybrechts","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"pmed.1004721.ref049","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/ije\/25.6.1107","article-title":"Basic methods for sensitivity analysis of biases","volume":"25","author":"S Greenland","year":"1996","journal-title":"Int J Epidemiol"},{"issue":"2","key":"pmed.1004721.ref050","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/oxfordjournals.aje.a115342","article-title":"Human teratogens, prenatal mortality, and selection bias","volume":"130","author":"MJ Khoury","year":"1989","journal-title":"Am J Epidemiol"},{"issue":"6","key":"pmed.1004721.ref051","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/ppe.12650","article-title":"Quantification of selection bias in studies of risk factors for birth defects among livebirths","volume":"34","author":"D Heinke","year":"2020","journal-title":"Paediatr Perinat Epidemiol"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004721","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T17:21:50Z","timestamp":1758043310000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004721"}},"subtitle":[],"editor":[{"given":"Lars \u00c5ke","family":"Persson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":51,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1004721","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,16]]}}}